Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma

Benjamin M. Ellingson, Dana T. Aftab, Gisela M. Schwab, Colin Hessel, Robert J. Harris, Davis C. Woodworth, Kevin Leu, Ararat Chakhoyan, Catalina Raymond, Jan Drappatz, John De Groot, Michael D. Prados, David A. Reardon, David Schiff, Marc Chamberlain, Tom Mikkelsen, Annick Desjardins, Jaymes Holland, Jerry Ping, Ron WeitzmanPatrick Y. Wen, Timothy F. Cloughesy

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences